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Abstract
Background: Immunoglobulin G (IgG) antibodies reactive with intracellular neuronal proteins
have been described in paraneoplastic and other autoimmune disorders. Because neurons have
been thought impermeable to immunoglobulins, however, such antibodies have been considered
unable to enter neurons and bind to their specific antigens during life. Cerebellar Purkinje cells - an
important target in paraneoplastic and other autoimmune diseases - have been shown in
experimental animals to incorporate a number of molecules from cerebrospinal fluid. IgG has also
been detected in Purkinje cells studied post mortem. Despite the possible significance of these
findings for human disease, immunoglobulin uptake by Purkinje cells has not been demonstrated in
living tissue or studied systematically.
Methods:  To assess Purkinje cell uptake of immunoglobulins, organotypic cultures of rat
cerebellum incubated with rat IgGs, human IgG, fluorescein-conjugated IgG, and rat IgM were
studied by confocal microscopy in real time and following fixation. An IgG-daunorubicin
immunotoxin was used to determine whether conjugation of pharmacological agents to IgG could
be used to achieve Purkinje cell-specific drug delivery.
Results: IgG uptake was detected in Purkinje cell processes after 4 hours of incubation and in
Purkinje cell cytoplasm and nuclei by 24-48 hours. Uptake could be followed in real time using IgG-
fluorochrome conjugates. Purkinje cells also incorporated IgM. Intracellular immunoglobulin did
not affect Purkinje cell viability, and Purkinje cells cleared intracellular IgG or IgM within 24-48
hours after transfer to media lacking immunoglobulins. The IgG-daunomycin immunotoxin was also
rapidly incorporated into Purkinje cells and caused extensive, cell-specific death within 8 hours.
Purkinje cell death was not produced by unconjugated daunorubicin or control IgG.
Conclusion: Purkinje cells in rat organotypic cultures incorporate and clear host (rat) and non-
host (human or donkey) IgG or IgM, independent of the immunoglobulin's reactivity with Purkinje
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cell antigens. This property permits real-time study of immunoglobulin-Purkinje cell interaction
using fluorochrome IgG conjugates, and can allow Purkinje cell-specific delivery of IgG-conjugated
pharmacological agents. Antibodies to intracellular Purkinje cell proteins could potentially be
incorporated intracellularly to produce cell injury. Antibodies used therapeutically, including
immunotoxins, may also be taken up and cause Purkinje cell injury, even if they do not recognize
Purkinje cell antigens.
Background
Antibodies to cytoplasmic components of cerebellar
Purkinje cells have been repeatedly described in sera and
cerebrospinal fluid (CSF) of patients developing paraneo-
plastic cerebellar degeneration in the setting of systemic
cancer, as well as in systemic lupus erythematosus and cer-
tain other disorders [1-7]. Despite their frequent detec-
tion, however, the roles of such antibodies in the
pathogenesis of neuronal injury have been uncertain.
Intact neurons have been thought to be essentially imper-
meable to IgG, and antibodies to cytoplasmic or nuclear
neuronal antigens have been considered unable to enter
neurons and bind to their intracellular target antigens dur-
ing life [8].
A possible exception to neuronal exclusion of antibodies
- and an important target in autoimmune neuronal injury
- is the cerebellar Purkinje cell. In experimental animals,
Purkinje cells have been shown capable of taking up a
variety of substances from ventricular CSF, including pro-
pidium iodide, granular blue, bisbenzimide, and horse-
radish peroxidase conjugated to wheat germ agglutinin [9-
11]. That Purkinje cells might also incorporate IgG has
been suggested by several older studies using fixed cere-
bellar tissue. Fabian and Ritchie, in 1986, reported immu-
nohistochemical staining for IgG in Purkinje cells and
occasional other neurons in rat brains [12]. In subsequent
studies, Karpiak detected antibodies to S100 protein
within Purkinje cells following intraventricular injection
[13]. Graus et al. detected both normal and anti-Yo IgG in
Purkinje cells of guinea pigs sacrificed after intraventricu-
lar IgG instillation [14]; and our own work demonstrated
IgG in Purkinje cells of rats sacrificed after intraperitoneal
IgG injection of anti-Yo IgG in the presence of blood-
brain barrier disruption [15]. In humans, uptake of IgG
has been suggested by the detection of kappa and lambda
light chains in Purkinje and certain other neurons of a
patient dying of multiple myeloma [16]. Despite these
observations, however, the ability of viable Purkinje cells
to incorporate antibody has never been studied systemat-
ically, and the use of post mortem material in all pub-
lished studies does not exclude the possibility of entry of
IgG into neurons after death. The ability of Purkinje and
related neurons to take up antibody is important not only
because of the possible role of autoantibodies in disease
causation but also because cerebellar injury and Purkinje
cell destruction have been described in animals and
human patients receiving IgG-conjugated immunotoxins
[17-20].
Organotypic (slice) cultures of rat or mouse cerebellum
provide a tissue culture system which allows sequential
study of Purkinje cell interaction with exogenous com-
pounds, including immunoglobulins, in a setting in
which Purkinje and other neurons maintain normal ana-
tomical relationships. In the present study, we demon-
strate that cerebellar Purkinje cells are able to take up and
clear both IgG and IgM during life. We also demonstrate
that IgG uptake is not limited to immunoglobulins of the
host species, that fluorochrome-conjugated IgGs can be
used to follow IgG uptake in real time, and that targeted
Purkinje cell destruction can be achieved following
uptake of an immunotoxin whose IgG is not reactive with
Purkinje cell antigens.
Methods
Immunoglobulins and immunoglobulin fluorochrome 
conjugates
Purified normal rat IgG, fluorescein-conjugated IgGs, and
purified rat IgM were obtained commercially (Invitrogen,
Carlsbad, CA). For immunotoxin studies and controls, the
monoclonal rat IgG antibody GK1.5 (American Type Cul-
ture Collection; ATCC TIB-207), specific for mouse CD4+
cells was isolated from supernatant using fast protein liq-
uid chromatography (FPLC)(Pharmacia, Nutley, New Jer-
sey) [21]. Integrity of each IgG and IgM reagent was
confirmed by subjecting each antibody to sodium
dodecylsulfate polyacrylimide gel electrophoresis (SDS-
PAGE) prior to its use in tissue culture experiments. To
exclude the possibility that immunoglobulin fragments
might develop during incubation experiments, media
containing each immunoglobulin was analyzed by SDS-
PAGE after being maintained for 24 hours at 37°C. Poten-
tial reactivity of the immunoglobulins for Purkinje cells
was excluded by reacting each IgG and IgM employed in
these studies with fixed and unfixed frozen sections of rat
cerebellum.
Preparation of daunorubicin-IgG immunotoxin
Daunorubicin (daunomycin) is an anthracycline antineo-
plastic agent which causes cytotoxicity by intercalating
with cellular DNA to produce DNA double-strand breaksJournal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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and by enhancing catalysis of oxidation-reduction reac-
tions and generating oxygen free radicals [22]. The com-
pound produces an intrinsic red fluorescence with an
excitation of 488 nm and emission of 595 nm [23]. Work
by Shen and Ryser demonstrated that conjugation of dau-
norubicin using a pH-sensitive cis-aconityl spacer resulted
in a compound which was stable at neutral pH but
released unaltered free daunorubicin at pH 4 or below
[24]. Diener et al. subsequently demonstrated that cou-
pling of daunorubicin by this method to a monoclonal
antibody specific for T cells produced a conjugate which
selectively eliminated the response of T lymphocytes to
concanavalin A in vitro [25].
To determine whether uptake of daunorubicin conjugated
to IgG could be used to target Purkinje cells specifically,
daunorubicin was covalently linked to the purified rat
monoclonal IgG, GK1.5, specific for mouse CD4+ cells
[24]. GK1.5 was first shown not to react with rat cerebellar
Purkinje cells in frozen or fixed section in either unconju-
gated or immunotoxin-conjugated forms (data not
shown). Preparation of the immunotoxin employed the
method of Shen et al. [24]. In brief, daunorubicin (Sigma-
Aldrich, St. Louis MO) was dissolved in 200 mM Tris HCl
pH 9.0 and the cis-aconitic anhydride (CAA)(Sigma) was
dissolved in absolute ethanol. Daunomycin and the CAA
spacer were mixed and reacted together at pH 9.0 for 15
minutes. The pH was then slowly lowered to 3.0 with
0.1N hydrochloric acid, and the mixture was incubated
for 15 minutes at room temperature. The sample was cen-
trifuged, and the pellet was resuspended in distilled water
and adjusted to pH 8.0 using 0.1N sodium hydroxide. The
daunomycin-CAA spacer mixture was then added to 1-
ethyl-3-methyl carbodiimide (Sigma) and purified IgG at
a mixture of 0.2:1.0:1.0, reacted overnight at room tem-
perature, and dialyzed extensively against phosphate-
buffered saline (PBS). The immunotoxin was quantified
by using extinction coefficients for IgG and for daunoru-
bicin, and integrity of the immunotoxin was established
by SDS-PAGE (see Results). Efficacy of the immunotoxin
had previously been proven by demonstrating its ability
to produce killing within one hour of incubation in a lym-
phoproliferative stimulation assay using con-A activated
mouse lymph node cells (data not shown) [25].
Organotypic cerebellar cultures
All aspects of animal handling and care were conducted
with local Institutional Animal Care and Use Committee
(IACUC) approval in an Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC)-
approved facility (The Veterans Affairs Salt Lake City
Health Care System Veterinary Medical Unit). The
method used to prepare cultures was modified from that
of Rothstein et al. [26]. In brief, 10-12 or 23-27 day old
Sprague-Dawley rat pups (Charles River, Germantown,
MD) were euthanized. Cerebellums were rapidly har-
vested and sectioned (200 μm) using a Lancer Vibratome,
Series 1000 (Technical Products International, St. Louis,
MO). Slices were collected in iced sterile Hank's balanced
salt solution (Invitrogen) containing glucose (6.4 mg/ml)
plus gentamicin (20 μg/ml). The cerebellar slices were
transferred onto the surfaces of 0.4 μm pore size 30-mm
Millipore Millicell-CM porous membranes (Millipore,
Temecula, CA)(2 slices/membrane) in culture wells con-
taining 1 ml of incubation medium with 25% heat inacti-
vated horse serum, 25% Hanks balanced salt solution
with 25.6 mg/ml glucose, and 50% minimum essential
media (MEM) (Gibco/Invitrogen) with 25 mM of HEPES
(Sigma), at a final pH of 7.2. Cultures were incubated at
37°C in a 5% CO2/95% humidified air environment
overnight before being used for experiments and were
then maintained with twice weekly changes of medium.
Resultant cultures exhibited typical cerebellar morphol-
ogy, with Purkinje cells clearly identifiable by morphol-
ogy and by positive immunostaining of Purkinje cells in
fixed cultures with both anti-Yo antibodies (data not
shown) and antisera to recombinant calbindin (Milli-
pore), a protein widely used as a marker for cerebellar
Purkinje cells[27,28](Figure 1). Cultures for each time
point were prepared from cerebellar slices from 4-6 ani-
mals. With the exception of real-time antibody uptake
studies, which employed day 24 animals, all experiments
were carried out using cultures derived from both younger
(day 10-12) and older (day 23-27) animals. All studies
were done in duplicate or triplicate. IgG concentrations
were adjusted to 7.5 μg/ml for all experiments; we had
found that this immunoglobulin concentration provided
optimal imaging of antibody uptake with minimal back-
ground fluorescence. No difference was noted in survival
of Purkinje or other neurons in cultures derived from
younger as opposed to older animals.
Studies of IgG uptake in living, unfixed cultures
The ability of living Purkinje cells to incorporate IgG in
real time was studied by incubating cultures from 24 day
old rats in media containing a 1:800 dilution of Cy5- or
FITC-conjugated donkey anti-human IgG, using this age
group because it more accurately reflects adult cerebellar
structure. These antibodies had been previously shown
not to label Purkinje cells in frozen section. Culture plates
were maintained in a heated microscope stage incubator
(SmartSlide microincubation chamber, WaferGen Biosys-
tems, Fremont CA) and studied at intervals for up to 48
hours.
Studies of IgG uptake and clearance using fixed cultures
To determine whether observations made in real time
could be duplicated in fixed cultures and to assess the
effect of intracellular IgG on cell survival, parallel cultures
were incubated with 7.5 μg/ml concentrations of normalJournal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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rat IgG. These cultures were fixed for study at intervals up
to 120 hours. To determine whether Purkinje cells were
able to clear incorporated IgG, organotypic cerebellar cul-
tures were incubated with 7.5 μg/ml dilutions of normal
rat IgG for 24 or 48 hours. Cultures were then placed in
tissue culture media lacking rat IgG, and harvested at
sequential intervals for 48 hours before being fixed, per-
meabilized, and labeled with Cy5-conjugated goat anti-
rat IgG (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA).
Incubation with IgM
To determine whether Purkinje cells were able to incorpo-
rate larger immunoglobulin molecules, organotypic cul-
tures were incubated in media containing 12.5 μg/ml of
purified rat IgM. Cultures were harvested at serial intervals
through 120 hours, fixed, permeabilized, and labeled
with Cy5-conjugated goat anti-rat IgM (Jackson). Ability
of Purkinje cells to clear IgM was assessed as described
above for IgG.
Incubation of cultures with Daunorubicin-IgG 
immunotoxin
Organotypic cerebellar cultures were incubated with 5 μg/
ml of daunorubicin-IgG/ml and were examined after 4, 6,
8, 24, and 48 hours. Controls included cultures incubated
for periods of up to 120 hours with unconjugated dauno-
rubicin at a concentration equal to that present in the dau-
norubicin-IgG conjugate (500 nM) or with an equivalent
concentration of the unconjugated monoclonal IgG.
Determination of Purkinje cell viability and quantitation of 
Purkinje cell death
Purkinje cells in animals have been shown to incorporate
a number of compounds from ventricular CSF including
propidium iodide and ethidium homodimer which are
excluded from most living cells and whose entry into cells
has been used as a markers for cell death [29](Greenlee et
al. submitted for publication). SYTOX green is a dye
which, like propidium iodide and ethidium homodimer,
is excluded from living cells but which readily enters dead
or dying cells to bind to intracellular nucleic acids [29].
We have found that SYTOX green is excluded from viable
Purkinje cells for periods of up to 24 hours but readily
enters Purkinje cells following cell death induced by exci-
totoxic agents, detergents, or exposure to reduced temper-
ature (Greenlee et al., submitted for publication). To
quantify Purkinje cell death, cultures were incubated with
either IgG or immunotoxin conjugates and SYTOX green
(25 nM) was added two hour prior to fixation and
immunofluorescence confocal microscopy. The amount
of cell death was quantified by a blinded observer and
consisted of counting of the number of cells labeled by
Cy5 conjugated IgG containing or lacking SYTOX green.
Live cells were recorded as containing Cy5-conjugated IgG
and lacking SYTOX green. Dead cells were scored as cells
co-labeled for IgG and SYTOX green. A minimum of four
fields was examined for each time point and the percent
of dead cells was calculated. Approximately 40-90 cells
were counted for each field and the average percentage cell
death was obtained from four fields captured at 40× mag-
nification. Statistical significance between groups was
examined using the non-parametric Mann-Whitney U-sta-
tistical analysis using GraphPad Instat statistical software
(GraphPad Software, Inc., La Jolla, Ca).
Immunofluorescence methods
Frozen sections of rat cerebellum used to exclude cross-
reactivity of our antibodies with Purkinje cells were stud-
ied by indirect immunofluorescence using Cy5-conju-
gated goat anti-rat IgG (Jackson) as previously described
[30,31]. Unfixed cultures studied for uptake of fluoro-
Neurons incorporating IgG contain calbindin, identifying them as Purkinje cells Figure 1
Neurons incorporating IgG contain calbindin, identifying them as Purkinje cells. Cultures were incubated with nor-
mal human IgG for intervals of up to 96 hours, fixed, permeabilized, and immunolabeled for calbindin (Panel A: blue) as a 
marker for Purkinje cells and IgG (Panel B: red). Panel C shows the merged image for both calbindin and IgG (magenta). Uptake 
of IgG is confined to cells expressing calbindin. (Objective magnification 40×)Journal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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chrome-conjugated IgG in real time used Cy-5 conjugated
or FITC-conjugated donkey anti-human IgG antibodies,
maintaining cultures in the microscope stage incubating
chamber. Cultures for more detailed study of Cy5 or FITC-
conjugated IgGs were fixed in 2% paraformaldehyde for 1
hour at room temperature but not permeabilized. To
detect unconjugated IgG or IgM within Purkinje cells, cul-
tures were fixed in 2% paraformaldehyde for 1 hour, per-
meabilized with 0.2% Triton X-100 for 1 hour 30
minutes, incubated overnight at 4°C with 1:800 dilutions
of Cy5-conjugated donkey anti-human IgG or IgM, (Jack-
son), and then washed and cover slipped using Prolong
Gold (Invitrogen).
Identification of Purkinje cells
Cerebellar Purkinje cells are usually recognizable in histo-
logical sections or cultures by virtue of their distinctive
morphology. In addition, this cell population can be
identified by immunolabeling for calbindin. To confirm
that cells incorporating immunoglobulins were Purkinje
cells, cultures incubated with immunoglobulin G and
were harvested at intervals through 96 hours. SYTOX
green was added to cultures two hours before harvesting
to assess cell viability. Cultures were then fixed in 2%
paraformaldehyde, permeabilized with Triton X-100 as
described above, and incubated for overnight at 4°C with
a 1:1000 dilution of rabbit anti-calbindin antibody
(Chemicon/Millipore AB1778, Temecula, CA). Cultures
were then incubated overnight at 4°C with Cy5-conju-
gated donkey anti-human IgG (1:800) and with Cy3-con-
jugated donkey anti-rabbit IgG (1:800)(Jackson) to
visualize calbindin, washed, and studied using confocal
microscopy.
Confocal microscopy
Confocal image acquisition employed a Nikon Eclipse
E800 upright microscope (Nikon Biosciences, Melville,
NY) and the Personal Confocal Microscopy PCM-2000
utilizing Argon-ion and green and red HeNe lasers to
acquire images. Simple Personal Confocal Image software
program (Compix, Cranberry Township, PA) was used for
acquisition of digital images and image analysis. A red
HeNe laser with a 633 nm excitation filter and 675 LP fil-
ter was used to visualize Cy5. A green HeNe laser with 543
excitation filter and 556 LP filter were used to visualize
Cy3. The Argon-ion laser was used with a 488 filter for
FITC, a 510 LP filter to image SYTOX green, and a 605 LP
filter to visualize daunorubicin. All filters were matched to
the peak emission spectrum of the fluorochromes
employed. General procedures utilized individual fluoro-
chromes with X, Y, and Z scans of 14-20 focal planes.
Identical focal plane settings for each fluorochrome were
used for single visual field analysis to ensure that each cor-
responding fluorochrome was imaged in the same focal
plane. In all studies, stringent uniform experimental
parameters and computer software settings were main-
tained for the respective image analyses. Because the
vibratome preparation techniques used to prepare organ-
otypic cultures invariably resulted in death of neurons on
the cut surfaces of culture slices, image analysis in all
experiments was confined to the interior portions of the
cultures.
Results
Confirmation of IgG and IgM integrity and lack of 
reactivity with Purkinje cells
To preclude the possibility that immunolabeling for IgG
or IgM might be due to potential IgG breakdown frag-
ments, the normal rat IgG, the IgG monoclonal GK 1.5,
and the normal rat IgM used in these experiments were
analyzed by SDS-PAGE. Media containing each of the
three immunoglobulins as used for initial culture incuba-
tion and after incubation at 37°C for 24 hours were ana-
lyzed under both under reducing (containing
dithiothreitol) and non-reducing (lacking dithiothreitol)
conditions. In reduced gels IgG produced bands at 55 kDa
and 26 kDa MW, and IgM bands of 75 kDa and 25 kDa
consistent with IgG and IgM heavy and light chains
respectively (Figure 2). In non-reducing gels, both IgG
and IgM produced single bands (data not shown). IgG or
IgM breakdown fragments were not detected under either
reducing or nonreducing conditions. No immunoreactiv-
ity with Purkinje cells was detected for the normal rat IgG,
the anti-CD4 monoclonal, GK 1.5, or the normal rat IgM
by immunofluorescence staining against fixed or unfixed
frozen sections of rat cerebellum (See methods; data not
shown), precluding the possibility that uptake of IgG by
Purkinje cells in our cultures was the result of antibody
binding to Purkinje cell membrane antigens.
Uptake of IgG by Purkinje cells
Cultures incubated with normal rat IgG were harvested at
time intervals from 2-48 hours. To confirm cell viability,
cultures were reacted with SYTOX green for two hours
prior to harvesting. Cultures were then fixed, mounted on
glass slides and analyzed by confocal microscopy. The
time course for uptake and clearance of the immunoglob-
ulin is shown in Table 1. Bright immunofluorescence
labeling specific for IgG was detected in Purkinje cell den-
drites within 4 hours (Table 1) and in Purkinje cell bodies
by 6 hours (Table 1)(Figure 3A). By 24 hours, IgG was
clearly detectable in the majority of Purkinje cells
throughout the cultures, with some cells showing IgG
within cell nuclei as well as cytoplasm. (Figure 3B).
Purkinje cells which incorporated IgG did not contain
SYTOX green, indicating that these cells were viable at the
time cultures were fixed. In other experiments, IgG-con-
taining Purkinje cells in cultures maintained for 120
hours continued to exclude SYTOX green, indicating that
the presence of IgG within Purkinje cells did not affect cellJournal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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viability (data not shown). To confirm the identity of the
cells taking up IgG as Purkinje cells, cultures were incu-
bated with normal human IgG for intervals up to 96
hours, fixed, permeabilized, incubated with rabbit anti-
calbindin antibody and then immunolabeled with Cy5-
conjugated anti-human IgG and Cy3-conjugated donkey
anti-rabbit IgG. Immunolabeling for IgG was shown to
colocalize with immunolabeling for calbindin (Figure 1),
confirming that the cells incorporating antibody were
Purkinje cells. In these cultures, occasional IgG-contain-
ing cells were also detected which had the morphological
characteristics of Purkinje cells but could not be shown to
express calbindin (Figure 1); this is consistent with work
by other investigators demonstrating that a minority of
Purkinje cells in rat organotypic do not label with anti-cal-
bindin antibodies [32]. Our results thus demonstrate that
rat cerebellar cultures might potentially be suitable for
studies of antibody-Purkinje cell interactions using
human immunoglobulins.
We next incubated cerebellar cultures with human IgG to
determine whether rat Purkinje cells were able to incorpo-
rate non-species immunoglobulin. Cultures were incu-
bated with 7.5 μg/ml concentrations of normal human
IgG, fixed, permeabilized, and labeled with Cy5-conju-
gated donkey anti-human IgG. Purkinje cell viability was
confirmed by exclusion of SYTOX green. The time course
of IgG uptake and intracellular distribution of human IgG
was identical to that of rat IgG (Table 1). Human IgG was
detectable in Purkinje cell processes within 4 hours, in
Purkinje cell cytoplasm by 6 hours (Figure 3D), and in cell
nuclei as well as cytoplasm by 24-48 hours (Figure
3E)(Table 1).
Demonstration of IgG clearance from Purkinje cells
To determine whether Purkinje cells could clear IgG once
it had been taken up intracellularly, organotypic cerebel-
lar cultures were maintained in media containing rat IgG
for 48 hours. The cultures were then transferred to media
lacking rat IgG and studied after 24-72 hours. In these
studies, Purkinje cells exhibited bright fluorescence spe-
cific for rat IgG after 48 hours of incubation with IgG.
After transfer to IgG-free media, immunofluorescence was
not detected after 24-48 hours, indicative of immu-
noglobulin clearance. (Figures 3C, 3F)(Table 1)
Real-time confirmation of IgG uptake
Organotypic cerebellar cultures were incubated with Cy5-
conjugated or FITC-conjugated donkey anti-human IgG
and studied over time in a heated microscope stage incu-
bator (see methods). In these experiments, Cy5-labeled
and FITC-labeled IgGs were detected in Purkinje cell den-
drites and rare cell bodies within 4 hours (Table 1). By 24
hours, Cy5-conjugated (Figure 4A) or FITC-conjugated
(Figure 4C) IgGs were present in the majority of Purkinje
cells throughout the cultures. Similar results were seen
with tissues subsequently fixed and examined under
higher magnification (Figures 4B and 4D).
Interaction of IgM with Purkinje cells
The ability of Purkinje cells to incorporate IgG raised
questions as to whether these cells could also take up
larger immunoglobulins such as IgM (molecular weight
950 kDa, compared to the 150 kDa weight of IgG). In cul-
tures incubated with normal IgM, positive immunofluo-
rescence staining for the immunoglobulin was detected
within 4 hours in Purkinje cell processes (Table 1) and by
6-24 hours within the cytoplasm of most Purkinje cells, as
well as within scattered Purkinje cell nuclei (Figures 3G,
3H). Viability of Purkinje cells incorporating IgM was
confirmed by exclusion of SYTOX green. As with IgG,
transfer of cultures to media lacking IgM resulted in disap-
SDS-PAGE of normal rat IgG and IgM used to assess immu- noglobulin uptake by Purkinje cells Figure 2
SDS-PAGE of normal rat IgG and IgM used to assess 
immunoglobulin uptake by Purkinje cells. SDS-PAGE 
demonstrates IgG bands at 55 kDa and 26 kDa MW and IgM 
bands of 75 kDa and 25 kDa. These molecular weights are 
consistent with IgG and IgM heavy and light chains and are 
labeled with "H" and "L" respectively. In non-reducing gels, 
both IgG and IgM produced single bands (data not shown). 
IgG or IgM breakdown fragments were not detected under 
either reducing or nonreducing conditions.Journal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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pearance of detectable immunofluorescence for the
immunoglobulin within 24-48 hours (Figure 3I), indica-
tive of clearance.
Targeted killing of Purkinje cells by daunorubicin-
conjugated IgG but not free daunorubicin
Since Purkinje cells were shown to take up IgG, we inves-
tigated whether Purkinje cell-specific delivery of agents
could be achieved by coupling them to IgG. To answer
this question, we studied the ability of an IgG-immunoto-
xin to produce targeted Purkinje cell death. Organotypic
cerebellar cultures were maintained in media containing 5
μg/ml of the daunorubicin-IgG immunotoxin and exam-
ined at 4, 6, 8, 24, and 48 hours. As controls, parallel cul-
tures were incubated for equal periods of time with either
the unconjugated IgG monoclonal or, to demonstrate that
coupling to IgG was essential for daunorubicin uptake by
Purkinje cells, with unconjugated daunorubicin present at
a concentration (500 nM) equal to the total amount of
daunorubicin contained in the IgG-immunotoxin conju-
gate (data not shown). SYTOX green was added to cultures
during the final two hours before fixation. Presence of the
IgG-daunorubicin complex within Purkinje cells and
SYTOX green staining were selectively studied using con-
focal microscopy. The time course for uptake of each com-
pound and their effect on cell viability are shown in Table
2. Within 4 hours after addition of the immunotoxin,
uptake of the IgG-daunorubicin complex was observed
within Purkinje cells as demonstrated by the intracellular
presence of fluorescence specific for daunorubicin (data
not shown) and by Cy5 immunolabeling specific for IgG.
In cultures studied at 4 hours, scattered Purkinje cells con-
tained SYTOX green, indicative of cell membrane injury
and death. After 8 hours of incubation 90% of Purkinje
cells containing the IgG-daunorubicin immunotoxin also
contained SYTOX green indicative of cell death, as indi-
cated by the presence of both IgG and SYTOX fluoro-
chromes (Figures 5, 6). Uptake of IgG in control cultures
paralleled that seen in cultures incubated with IgG-dauno-
rubicin, but cell death was observed in less than 5% of
cells (Figures 5, 6). Purkinje cells in organotypic cultures
incubated with concentrations of free daunorubicin equal
to those conjugated to the immunotoxin showed no evi-
dence of uptake and no increase in numbers of dead cells
(Table 2), indicating that the presence of IgG was required
to achieve toxic intracellular concentrations of daunoru-
bicin.
Discussion
Early in vivo studies suggesting potential uptake of IgG by
cerebellar Purkinje cells were limited to methodologies
employing fixed, post mortem material. These studies did
not exclude the possibility of IgG entry into Purkinje cells
after death, nor could they follow in real time, in a given
animal, the course of IgG uptake, the effect of incorpo-
rated IgG on Purkinje cell viability, or whether these large
neurons are able to clear IgG over time.
The present study demonstrates several important find-
ings: 1) IgG is rapidly taken up by viable Purkinje cells in
organotypic cultures as confirmed by colocalization of
immunostaining for IgG and the Purkinje cell marker, cal-
bindin. 2) The time course of IgG uptake by Purkinje cells
in organotypic cultures parallels that described by Graus
et al. in guinea pigs studied post mortem following intra-
ventricular administration of IgG [14]. 3) IgG uptake can
occur without specific antibody reactivity with Purkinje
cell surface antigens. 4) Rat Purkinje cells are able to incor-
porate IgG from other species including humans, suggest-
ing that this tissue culture system could potentially be
used to study interaction of human antibodies with
Purkinje cells. 5) Fluorochrome-conjugated (FITC or Cy5)
IgG can be used to study antibody uptake by living
Purkinje cells in real time. Intracellular IgG per se does not
Table 1: Time course of IgG and IgM uptake and clearance by Purkinje cells in organotypic cerebellar cultures
Immunoglobulin Immunoglobulin localization within Purkinje cellsa Immunoglobulin clearance from Purkinje cellsb
IgGsc 4 hours: Purkinje cell processes. Rare Purkinje cell bodies
6-8 hours: Purkinje cell processes and cytoplasm
24-48 hours: Most Purkinje cells (processes, cytoplasm, and nuclei)
24-48 hours
Normal Rat IgM 4 hours: Purkinje cell processes. Rare Purkinje cell bodies
6-8 hours: Purkinje cell processes and cytoplasm
24 hours: Most Purkinje cells 
(processes, cytoplasm, and some nuclei)
48 hours: Most Purkinje cells (processes, cytoplasm, and nuclei)
24-48 hours
a. Purkinje cell death was observed in <5% of cells through 120 hours of incubation as indicated by intracellular presence of the cell death marker, 
SYTOX green. Cell death was equivalent to that seen in cultures incubated without immunoglobulin.
b. Following transfer of cultures to media not containing the immunoglobulin
c. IgGs: normal rat IgG, GK1.5 monoclonal rat anti-CD4+ antibody, normal human IgG, Cy5-conjugated donkey anti-human IgG, FITC-conjugated 
donkey anti-human IgG. Cy5-conjugated donkey anti-human IgG and FITC-conjugated donkey anti-human IgG were studied both in real time in 
living cultures and following fixation.Journal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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appear to affect Purkinje cell viability, and IgG is cleared
from Purkinje cells after its removal from culture media.
Somewhat surprisingly, viable Purkinje cells were also
able to incorporate IgM, a much larger molecule. Our
studies also demonstrated that Purkinje cells were also
able to incorporate an IgG-daunorubicin immunotoxin
complex and that the internalized immunotoxin rapidly
caused Purkinje cell death without appreciable death of
other neuronal populations over the time period studied.
In contrast, Purkinje cells in cultures incubated with an
equivalent amount of free daunorubicin remained viable,
indicating that the uptake and subsequent toxic effect of
daunorubicin for Purkinje cells required uptake of the
toxin through its coupling to IgG. These data indicate that
normal IgG can be used to target Purkinje cells for specific
intracellular delivery of pharmacological agents. Although
the present study dealt with a single cytotoxic agent, this
method may potentially be applicable to Purkinje cell
delivery of other IgG-conjugated molecules.
In our studies, both IgG and IgM appeared initially in
Purkinje cell processes, followed by detection of IgG in
cytoplasm and then in cell nuclei. These observations sug-
gest that IgG within Purkinje cells accumulates in cell
nuclei as well as cytoplasm. This finding has not previ-
ously been reported. However, intracellular trafficking of
Uptake and clearance of rat and human IgG and rat IgM by Purkinje cells over time Figure 3
Uptake and clearance of rat and human IgG and rat IgM by Purkinje cells over time. Uptake of rat IgG (Panels A, 
B), human IgG (Panels D, E), and rat IgM (Panels G, H) (red) is demonstrated in Purkinje cells studied at 6 hours (Panels A, D, 
G), with more extensive uptake visible at 24 hours (Panels B, E, H). In these figures Cy5 labels immunoglobulins red. IgG or IgM 
are no longer detectable in cultures studied after 24-48 hour incubation after transfer to media lacking the immunoglobulin 
(Panels C, F, I). Yellow fluorescence, as would be indicative of SYTOX green staining of dead cells containing IgG was not 
apparent. (Objective magnification 40×)Journal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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other proteins is well known to occur in neurons [33-36],
and studies of molecules injected into non-neuronal cell
types have demonstrated similar intracellular trafficking
of proteins - including injected antibodies - from cyto-
plasm into cell nuclei [37-40].
IgM is a pentameric molecule with a molecular weight of
950 kDa, and given its large molecular weight, we had not
expected it to be incorporated by Purkinje cells. Some-
what to our surprise, the molecule was readily incorpo-
rated into Purkinje cells and achieved intracellular
cytoplasmic and nuclear distribution similar to that
observed by IgG. As in the case of IgG, Purkinje cells
appeared to tolerate intracellular IgM without effect on
cell viability and were able to clear IgM following its
removal from culture media.
The mechanisms by which Purkinje cells incorporate mol-
ecules are not well understood. Borges found that uptake
of propidium iodide was blocked in vivo by pretreatment
Uptake in real time and in fixed tissues showing SYTOX exclusion and IgG clearance Figure 4
Uptake in real time and in fixed tissues showing SYTOX exclusion and IgG clearance. Cy5-labeled (red) and FITC-
labeled (green) IgGs are demonstrated in Purkinje cell processes and cytoplasm in living cultures studied at 24 hours (Panels A, 
C)(Objective magnification 20×). Similar results were seen with tissues subsequently fixed and examined under higher magnifi-
cation (Panels B, D)(Objective magnification 40×).
Table 2: Interaction of GK1.5 IgG monoclonal, free daunorubicin, and GK1.5-daunorubicin immunotoxin with Purkinje cells
Reagent Uptake by Purkinje cells Purkinje cell deatha
GK1.5 monoclonal rat anti-CD4+ antibody Identical to normal rat IgG (See Table 1) <5% of cellsb
Unconjugated (free) daunorubicin No detectable uptake <5% of cellsb
GK1.5-daunorubicin immunotoxin Initial uptake at 4 hours
Widespread uptake by 6 hours
6 hours: <10% of cells
8 hours: 90% of cells
a. As indicated by intracellular presence of the cell death marker, SYTOX green in cells containing the IgG immunotoxin.
b. At 8 hoursJournal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
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of animals with colchicine and also by ouabain, suggest-
ing that uptake required active transport and possibly
involved microtubules [9]. Whether similar mechanisms
are involved in uptake of IgG or IgM is not known, and
studies are currently in progress to determine whether
uptake of IgG or IgM can be blocked using these com-
pounds or other agents known to interfere with active
transport across cell membranes.
The ability of cerebellar Purkinje cells to incorporate not
only IgG but also IgG-conjugated immunotoxins may
have applicability to the use of monoclonal IgGs or IgG
immunotoxins in the treatment of human disease. Two
early animal studies involving intraventricular injection
of immunotoxins demonstrated Purkinje cell loss.
Muraszko et al. noted Purkinje cell loss in rats and mon-
keys receiving intrathecal injections of ricin A chain con-
jugated to monoclonal antibodies reactive with
transferrin receptors [18]. These authors attributed
Purkinje cell loss to immunotoxin-induced CSF eosi-
nophilia [18]. Davis and Wiley demonstrated Purkinje
cell loss in rats after intraventricular injection of saponin
conjugated to OX7, an antibody directed against Thy1
[19]. The antibodies used by both Muraszko et al. and by
Davis and Wiley were known to react with antigens
present on Purkinje cells [41-43]. In contrast, Pai et al.
treated 23 patients with advanced, refractory epithelial
carcinoma of the ovary with intraperitoneal infusions of
pseudomonas exotoxin conjugated to a mouse mono-
clonal IgG2b antibody, OVB3 (OVB3-PE). OVB3 had been
generated by immunizing mice with cell membranes from
the human ovarian carcinoma cell line, OVCAR-3 [20].
OVB3-PE had been found to be safe in studies of mice and
monkeys and to be effective against all ovarian cancers
tested in culture [20,44-46]. The study was terminated,
however, after three patients developed severe, in one case
fatal encephalopathies. In the patient developing fatal dis-
ease, CSF was found to have extreme elevation of protein.
MRI showed areas of increased signal and gadolinium
enhancement in cerebellum, deep cerebellar nuclei, and
brainstem. Animal studies with OVB-PE had not demon-
strated reactivity with neural tissue. However, our study
Cultures incubated with GK1.5 IgG-daunorubicin immunotoxin or with GK1.5 antibody control, scored for cell death Figure 5
Cultures incubated with GK1.5 IgG-daunorubicin immunotoxin or with GK1.5 antibody control, scored for cell 
death. Cultures were incubated with either the immunotoxin (Panel A) or control IgG (Panel B) for 8 hours. SYTOX green 
was added during the last two hours of incubation to detect cell death prior to fixation and immunostaining for IgG. Cy5 labe-
ling of IgG appears red. Intracellular presence of SYTOX, indicating cell death, appears green. Colabeling for IgG and SYTOX 
appears yellow. The SYTOX green channel is shown for the immunotoxin (Panel C) and control IgG (Panel D). Examples of 
cells scored as live cells (positive for IgG and negative for SYTOX green) are indicated with gray horizontal arrows, while 
examples of dead cells positive for IgG and SYTOX green are indicated with a white vertical arrow. (Objective magnification 
40×)Journal of Neuroinflammation 2009, 6:31 http://www.jneuroinflammation.com/content/6/1/31
Page 11 of 12
(page number not for citation purposes)
suggests that uptake of the immunotoxin into Purkinje
cells and possibly other neurons could have occurred
without actual antibody specificity. The ability of Purkinje
cells to incorporate IgG and IgM may have relevance to
the role of antibodies in paraneoplastic or other neuronal
death. In addition, the ability of Purkinje cells to incorpo-
rate molecules conjugated to IgG provides a potential tool
for pharmacological studies involving Purkinje cells and
also a cautionary note for the use of IgG conjugates in
treatment of human disease.
Conclusion
We conclude that Purkinje cells in rat organotypic cultures
are able to take up and clear host (rat) and non-host (don-
key or human) IgG independent of the immunoglobulin's
reactivity with Purkinje cell antigens. The cells are also
able to incorporate and clear IgM. This property permits
specific targeting of Purkinje cells using both fluoro-
chrome IgG conjugates, allowing study of Purkinje cell-
IgG interaction in real time, and also IgG immunotoxins
or possibly conjugates of other pharmacological agents.
Our studies suggest that paraneoplastic or other autoanti-
bodies reactive with nuclear or cytoplasmic Purkinje cells
antigens might also be taken up intracellularly and could
potentially produce cell injury and death. Our data also
indicate that antibodies used therapeutically, including
monoclonal agents and immunotoxins could also be
taken up and cause Purkinje cell injury, even if they do not
recognize Purkinje cell antigens.
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